Xolair omalizumab: Completed Phase III enrollment

By WIR Staff | Jan 15, 2007 | 8:00 AM GMT

DNA said last quarter NVS completed enrollment in a 1-year Phase

Read the full 110 word article

How to gain access

Continue reading with a
two-week free trial.